Identification of Conserved Amino Acid Residues in Rat Liver Carnitine Palmitoyltransferase I Critical for Malonyl-CoA Inhibition
暂无分享,去创建一个
Alfonso Valencia | Montserrat Morillas | Paulino Gómez-Puertas | Dolors Serra | A. Valencia | P. Gómez-Puertas | N. Casals | F. Hegardt | D. Serra | G. Asins | Guillermina Asins | Fausto G Hegardt | Assia Bentebibel | M. Morillas | Assia Bentebibel | Eva Sellés | Nuria Casals | Eva Sellés
[1] G. Ronnett,et al. The connections between C75 and obesity drug-target pathways. , 2005, Trends in pharmacological sciences.
[2] L. Tong,et al. Crystal Structure of Mouse Carnitine Octanoyltransferase and Molecular Determinants of Substrate Selectivity*[boxs] , 2005, Journal of Biological Chemistry.
[3] T. Seng,et al. C75 [4-Methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic Acid] Activates Carnitine Palmitoyltransferase-1 in Isolated Mitochondria and Intact Cells without Displacement of Bound Malonyl CoA , 2005, Journal of Pharmacology and Experimental Therapeutics.
[4] D. Haro,et al. Pig muscle carnitine palmitoyltransferase I (CPTI beta), with low Km for carnitine and low sensitivity to malonyl-CoA inhibition, has kinetic characteristics similar to those of the rat liver (CPTI alpha) enzyme. , 2004, Biochemistry.
[5] R. Ramsay,et al. Carnitine acyltransferases and their influence on CoA pools in health and disease. , 2004, Molecular aspects of medicine.
[6] M. Golovko,et al. An improved method for tissue long-chain acyl-CoA extraction and analysis Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.D400004-JLR200 , 2004, Journal of Lipid Research.
[7] Antonio G. Cordente,et al. Redesign of Carnitine Acetyltransferase Specificity by Protein Engineering* , 2004, Journal of Biological Chemistry.
[8] G. Ronnett,et al. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. , 2004, American journal of physiology. Endocrinology and metabolism.
[9] B. Corkey,et al. Increased β-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation* , 2004, Journal of Biological Chemistry.
[10] Alfonso Valencia,et al. Structural model of carnitine palmitoyltransferase I based on the carnitine acetyltransferase crystal. , 2004, The Biochemical journal.
[11] E. Park,et al. Peroxisomal proliferator activated receptor gamma coactivator (PGC-1alpha) stimulates carnitine palmitoyltransferase I (CPT-Ialpha) through the first intron. , 2004, Biochimica et biophysica acta.
[12] M. Lane,et al. Hypothalamic malonyl-CoA as a mediator of feeding behavior , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[13] Manuel C. Peitsch,et al. SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..
[14] Roberto Conti,et al. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production , 2003, Nature Medicine.
[15] D. Arvidson,et al. Substitution of glutamate-3, valine-19, leucine-23, and serine-24 with alanine in the N-terminal region of human heart muscle carnitine palmitoyltransferase I abolishes malonyl CoA inhibition and binding. , 2003, Archives of biochemistry and biophysics.
[16] R. McKenna,et al. Structure of Human Carnitine Acetyltransferase , 2003, The Journal of Biological Chemistry.
[17] J. Dai,et al. Identification by Mutagenesis of Conserved Arginine and Glutamate Residues in the C-terminal Domain of Rat Liver Carnitine Palmitoyltransferase I That Are Important for Catalytic Activity and Malonyl-CoA Sensitivity* , 2003, The Journal of Biological Chemistry.
[18] Alfonso Valencia,et al. Identification of Conserved Amino Acid Residues in Rat Liver Carnitine Palmitoyltransferase I Critical for Malonyl-CoA Inhibition , 2003, The Journal of Biological Chemistry.
[19] L. Tong,et al. Crystal Structure of Carnitine Acetyltransferase and Implications for the Catalytic Mechanism and Fatty Acid Transport , 2003, Cell.
[20] R. Seeley,et al. Comparison of central and peripheral administration of C75 on food intake, body weight, and conditioned taste aversion. , 2002, Diabetes.
[21] Nigel Price,et al. A novel brain-expressed protein related to carnitine palmitoyltransferase I. , 2002, Genomics.
[22] P. Terpstra,et al. Structural and Functional Genomics of the CPT1B Gene for Muscle-type Carnitine Palmitoyltransferase I in Mammals* , 2002, The Journal of Biological Chemistry.
[23] G. Ronnett,et al. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] Alfonso Valencia,et al. Structural Model of a Malonyl-CoA-binding Site of Carnitine Octanoyltransferase and Carnitine Palmitoyltransferase I , 2002, The Journal of Biological Chemistry.
[25] Monica V. Kumar,et al. Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Schaffer. Fatty acid transport: the roads taken. , 2002, American journal of physiology. Endocrinology and metabolism.
[27] Monica V. Kumar,et al. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[28] Montserrat Morillas,et al. Structural Model of the Catalytic Core of Carnitine Palmitoyltransferase I and Carnitine Octanoyltransferase (COT) , 2001, The Journal of Biological Chemistry.
[29] W. Winder. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. , 2001, Journal of applied physiology.
[30] F. Kuhajda,et al. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. , 2001, Biochemical and biophysical research communications.
[31] I. S. Pretorius,et al. Carnitine‐dependent metabolic activities in Saccharomyces cerevisiae: three carnitine acetyltransferases are essential in a carnitine‐dependent strain , 2001, Yeast.
[32] J. Girard,et al. Molecular and enzymatic characterization of a unique carnitine palmitoyltransferase 1A mutation in the Hutterite community. , 2001, Molecular genetics and metabolism.
[33] J. Nuss,et al. Current therapies and emerging targets for the treatment of diabetes. , 2001, Current pharmaceutical design.
[34] F. R. van der Leij,et al. Molecular enzymology of carnitine transfer and transport. , 2001, Biochimica et biophysica acta.
[35] X. Ariza,et al. A Concise Synthesis of (-)-Methylenolactocin and (-)-Phaseolinic Acid from (6S,9S)-Tetradec-7-yne-6,9-diol , 2001 .
[36] N. Price,et al. Identification of Positive and Negative Determinants of Malonyl-CoA Sensitivity and Carnitine Affinity within the Amino Termini of Rat Liver- and Muscle-type Carnitine Palmitoyltransferase I* , 2000, The Journal of Biological Chemistry.
[37] D. Sharma,et al. Temporal formation of distinct thyroid hormone receptor coactivator complexes in HeLa cells. , 2000, Molecular endocrinology.
[38] E. Crockett,et al. Endpoint fluorometric assays for determining activities of carnitine palmitoyltransferase and citrate synthase. , 2000, Analytical biochemistry.
[39] C. Townsend,et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. , 2000, Science.
[40] D. Ritchie,et al. Protein docking using spherical polar Fourier correlations , 2000, Proteins.
[41] H. Zhu,et al. The first 28 N-terminal amino acid residues of human heart muscle carnitine palmitoyltransferase I are essential for malonyl CoA sensitivity and high-affinity binding. , 2000, Biochemistry.
[42] H. Zhu,et al. Functional characterization of mammalian mitochondrial carnitine palmitoyltransferases I and II expressed in the yeast Pichia pastoris. , 2000, The Journal of nutrition.
[43] F. Hegardt,et al. Identification of the two histidine residues responsible for the inhibition by malonyl‐CoA in peroxisomal carnitine octanoyltransferase from rat liver , 2000, FEBS letters.
[44] C. Townsend,et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. , 2000, Cancer research.
[45] V. Zammit. The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. , 1999, The Biochemical journal.
[46] D. Hardie,et al. AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.
[47] I R Vetter,et al. Effector Recognition by the Small GTP-binding Proteins Ras and Ral* , 1999, The Journal of Biological Chemistry.
[48] V A Zammit,et al. Carnitine acyltransferases: functional significance of subcellular distribution and membrane topology. , 1999, Progress in lipid research.
[49] H. Zhu,et al. A Single Amino Acid Change (Substitution of Glutamate 3 with Alanine) in the N-terminal Region of Rat Liver Carnitine Palmitoyltransferase I Abolishes Malonyl-CoA Inhibition and High Affinity Binding* , 1999, The Journal of Biological Chemistry.
[50] Demetrios Vavvas,et al. Malonyl-CoA, fuel sensing, and insulin resistance. , 1999, American journal of physiology. Endocrinology and metabolism.
[51] D. Carling,et al. Evidence that the AMP‐activated protein kinase stimulates rat liver carnitine palmitoyltransferase I by phosphorylating cytoskeletal components , 1998, FEBS letters.
[52] J. McGarry,et al. Roles of the N- and C-terminal domains of carnitine palmitoyltransferase I isoforms in malonyl-CoA sensitivity of the enzymes: insights from expression of chimaeric proteins and mutation of conserved histidine residues. , 1998, The Biochemical journal.
[53] Joseph A. DiGiuseppe,et al. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. , 1998, Cancer research.
[54] C N Cronin,et al. Redesign of Choline Acetyltransferase Specificity by Protein Engineering* , 1998, The Journal of Biological Chemistry.
[55] T. Gulick,et al. Expression of novel isoforms of carnitine palmitoyltransferase I (CPT-1) generated by alternative splicing of the CPT-ibeta gene. , 1998, The Biochemical journal.
[56] J. Cregg,et al. Deletion of the conserved first 18 N-terminal amino acid residues in rat liver carnitine palmitoyltransferase I abolishes malonyl-CoA sensitivity and binding. , 1998, Biochemistry.
[57] J. Girard,et al. Topological and functional analysis of the rat liver carnitine palmitoyltransferase 1 expressed in Saccharomyces cerevisiae , 1998, FEBS letters.
[58] R. Anderson. Carnitine palmitoyltransferase: a viable target for the treatment of NIDDM? , 1970, Current pharmaceutical design.
[59] T. Gulick,et al. Rat carnitine palmitoyltransferase Ibeta mRNA splicing isoforms. , 1998, Biochimica et biophysica acta.
[60] J. Cregg,et al. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I. , 1997, Archives of biochemistry and biophysics.
[61] P. Watkins. Fatty acid activation. , 1997, Progress in lipid research.
[62] J. McGarry,et al. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.
[63] J. Graham,et al. Subcellular fractionation : a practical approach , 1997 .
[64] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[65] G. Velasco,et al. Involvement of Ca2+/calmodulin-dependent protein kinase II in the activation of carnitine palmitoyltransferase I by okadaic acid in rat hepatocytes. , 1997, The Biochemical journal.
[66] P. Watkins,et al. Phytanic acid activation in rat liver peroxisomes is catalyzed by long-chain acyl-CoA synthetase. , 1996, Journal of lipid research.
[67] C. Sander,et al. Errors in protein structures , 1996, Nature.
[68] J. McGarry,et al. Expression of a cDNA Isolated from Rat Brown Adipose Tissue and Heart Identifies the Product as the Muscle Isoform of Carnitine Palmitoyltransferase I (M-CPT I) , 1996, The Journal of Biological Chemistry.
[69] M C Peitsch,et al. ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. , 1996, Biochemical Society transactions.
[70] B. Rost. PHD: predicting one-dimensional protein structure by profile-based neural networks. , 1996, Methods in enzymology.
[71] D S Goodsell,et al. Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.
[72] R A Sayle,et al. RASMOL: biomolecular graphics for all. , 1995, Trends in biochemical sciences.
[73] J. Girard,et al. Hormonal and nutritional control of liver fatty acid oxidation and ketogenesis during development. , 1995, Biochemical Society transactions.
[74] V. Anderson,et al. 13C NMR and 1H-1H NOEs of Coenzyme-A: Conformation of the Pantoic Acid Moiety , 1995 .
[75] N. Yamazaki,et al. High expression of a novel carnitine palmitoyltransferase I like protein in rat brown adipose tissue and heart: isolation and characterization of its cDNA clone , 1995, FEBS letters.
[76] C. Sander,et al. A method to predict functional residues in proteins , 1995, Nature Structural Biology.
[77] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[78] H. Lodish,et al. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein , 1994, Cell.
[79] J. McGarry,et al. Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. , 1994, The Journal of biological chemistry.
[80] J. Girard,et al. Expression of liver carnitine palmitoyltransferase I and II genes during development in the rat. , 1994, The Biochemical journal.
[81] K. Kashfi,et al. Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation. , 1994, Biochimica et biophysica acta.
[82] K. Kashfi,et al. Yonetani-Theorell analysis of hepatic carnitine palmitoyltransferase-I inhibition indicates two distinct inhibitory binding sites. , 1994, The Journal of biological chemistry.
[83] L. Witters,et al. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. , 1993, The Journal of biological chemistry.
[84] M. Sippl. Recognition of errors in three‐dimensional structures of proteins , 1993, Proteins.
[85] J. McGarry,et al. Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. , 1993, The Journal of biological chemistry.
[86] R. Ramsay,et al. Malonyl-CoA inhibition of peroxisomal carnitine octanoyltransferase. , 1992, The Biochemical journal.
[87] B. Fibich,et al. Restoration of malonyl-CoA sensitivity of soluble rat liver mitochondria carnitine palmitoyltransferase by reconstitution with a partially purified malonyl-CoA binding protein. , 1992, Archives of biochemistry and biophysics.
[88] R. Ramsay,et al. Effect of carboxylic acid xenobiotics and their metabolites on the activity of carnitine acyltransferases. , 1991, The Biochemical journal.
[89] J. Girard,et al. Evidence that the sensitivity of carnitine palmitoyltransferase I to inhibition by malonyl-CoA is an important site of regulation of hepatic fatty acid oxidation in the fetal and newborn rabbit. Perinatal development and effects of pancreatic hormones in cultured rabbit hepatocytes. , 1990, The Biochemical journal.
[90] C. Slaughter,et al. Cloning, sequencing, and expression of a cDNA encoding rat liver mitochondrial carnitine palmitoyltransferase II. , 1990, The Journal of biological chemistry.
[91] G Vriend,et al. WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.
[92] James J. P. Stewart,et al. MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..
[93] D. Taylor,et al. A simple enzymatic method for the preparation of radiolabeled erucoyl-CoA and other long-chain fatty acyl-CoAs and their characterization by mass spectrometry. , 1990, Analytical biochemistry.
[94] P. Selby,et al. Substituted 2-oxiranecarboxylic acids: a new group of candidate hypoglycaemic drugs. , 1989, Trends in pharmacological sciences.
[95] J. Reardon. Herpes simplex virus type 1 and human DNA polymerase interactions with 2'-deoxyguanosine 5'-triphosphate analogues. Kinetics of incorporation into DNA and induction of inhibition. , 1989, The Journal of biological chemistry.
[96] K. Thampy. Formation of malonyl coenzyme A in rat heart. Identification and purification of an isozyme of A carboxylase from rat heart. , 1989, The Journal of biological chemistry.
[97] D. Stump,et al. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. , 1988, The Journal of clinical investigation.
[98] S. Wakil,et al. Regulation of acetyl-coenzyme A carboxylase. I. Purification and properties of two forms of acetyl-coenzyme A carboxylase from rat liver. , 1988, The Journal of biological chemistry.
[99] D. Stump,et al. Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[100] P E Declercq,et al. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. , 1987, The Journal of biological chemistry.
[101] J. McGarry,et al. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. II. Use of detergents and antibodies. , 1987, The Journal of biological chemistry.
[102] A. Engel,et al. Different sites of inhibition of carnitine palmitoyltransferase by malonyl-CoA, and by acetyl-CoA and CoA, in human skeletal muscle. , 1987, The Biochemical journal.
[103] J. Morrison,et al. Mechanism of inhibition of dihydrofolate reductases from bacterial and vertebrate sources by various classes of folate analogues. , 1986, Biochimica et biophysica acta.
[104] V. Zammit,et al. Binding of [14C]malonyl-CoA to rat liver mitochondria after blocking of the active site of carnitine palmitoyltransferase I. Displacement of low-affinity binding by palmitoyl-CoA. , 1986, The Biochemical journal.
[105] V. Zammit,et al. Effects of incubation at physiological temperatures on the concentration-dependence of [2-14C]malonyl-CoA binding to rat liver mitochondria. , 1985, The Biochemical journal.
[106] E. Saggerson,et al. Interacting effects of L-carnitine and malonyl-CoA on rat liver carnitine palmitoyltransferase. , 1985, The Biochemical journal.
[107] W. Stremmel,et al. Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes. , 1985, The Journal of clinical investigation.
[108] E. Saggerson,et al. Binding of malonyl-CoA to isolated mitochondria. Evidence for high- and low-affinity sites in liver and heart and relationship to inhibition of carnitine palmitoyltransferase activity. , 1984, The Biochemical journal.
[109] V. Zammit,et al. Changes in the ability of malonyl-CoA to inhibit carnitine palmitoyltransferase I activity and to bind to rat liver mitochondria during incubation in vitro. Differences in binding at 0 degree C and 37 degrees C with a fixed concentration of malonyl-CoA. , 1984, The Biochemical journal.
[110] J. McGarry,et al. Effects of pH on the interaction of substrates and malonyl-CoA with mitochondrial carnitine palmitoyltransferase I. , 1984, The Biochemical journal.
[111] V. Zammit. Time-dependence of inhibition of carnitine palmitoyltransferase I by malonyl-CoA in mitochondria isolated from livers of fed or starved rats. Evidence for transition of the enzyme between states of low and high affinity for malonyl-CoA. , 1984, The Biochemical journal.
[112] C. Long,et al. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. , 1983, The Biochemical journal.
[113] R. Harris,et al. Effect of pH on malonyl-CoA inhibition of carnitine palmitoyltransferase I. , 1983, The Biochemical journal.
[114] E. Saggerson. Carnitine acyltransferase activities in rat liver and heart measured with palmitoyl-CoA and octanoyl-CoA. Latency, effects of K+, bivalent metal ions and malonyl-CoA. , 1982, The Biochemical journal.
[115] E. Saggerson,et al. Malonyl CoA inhibition of carnitine acyltransferase activities , 1982, FEBS letters.
[116] E. Saggerson,et al. Effects of fasting and malonyl CoA on the kinetics of carnitine palmitoyltransferase and carnitine octanoyltransferase in intact rat liver mitochondria , 1981, FEBS letters.
[117] E. Saggerson,et al. Carnitine palmitoyltransferase and carnitine octanoyltransferase activities in liver, kidney cortex, adipocyte, lactating mammary gland, skeletal muscle and heart , 1981, FEBS letters.
[118] J. Gollan,et al. Receptor for albumin on the liver cell surface may mediate uptake of fatty acids and other albumin-bound substances. , 1981, Science.
[119] G. Tutwiler,et al. Inhibition of mitochondrial carnitine palmitoyl transferase by 2-tetradecylglycidic acid (McN-3802) (preliminary communication). , 1980, Life sciences.
[120] P. Seglen. Preparation of isolated rat liver cells. , 1976, Methods in cell biology.
[121] I. H. Segel. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems , 1975 .
[122] J. Bremer,et al. The mechanism of substrate inhibition of palmityl coenzyme A:carnitine palmityltransferase by palmityl coenzyme A. , 1967, The Journal of biological chemistry.